Dr. Lopes-Virella is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
171 Ashley Ave
Charleston, SC 29425Phone+1 843-792-1414Fax+1 843-937-6110
Education & Training
- Medical University of South CarolinaResidency, Pathology-Anatomic and Clinical, 1978 - 1979
- University of Lisbon Faculty of MedicineClass of 1967
Certifications & Licensure
- SC State Medical License 1979 - 2025
- American Board of Pathology Clinical Pathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Markers and Mechanisms of Macrovascular Disease in IDDM Start of enrollment: 1996 Sep 01
Publications & Presentations
PubMed
- 29 citationsChlamydophila pneumoniae Induces ICAM-1 Expression in Human Aortic Endothelial Cells via Protein Kinase C–Dependent Activation of Nuclear Factor-κBSilvana A. Vielma, Gregor Krings, Maria F. Lopes-Virella
Circulation Research. 2003-05-30 - 54 citationsDecreased plasma levels of select very long chain ceramide species Are associated with the development of nephropathy in type 1 diabetesRichard L. Klein, Samar M. Hammad, Nathaniel L. Baker, Kelly J. Hunt, Mohammed M. Al Gadban
Metabolism. 2014-10-01 - 447 citationsThe Agenda for Familial Hypercholesterolemia A Scientific Statement From the American Heart AssociationSamuel S. Gidding, Mary Ann Champagne, Sarah D. de Ferranti, Joep C. Defesche, Matthew K. Ito
Circulation. 2015-12-01
Grant Support
- Biomarkers Of Vascular Disease Progression In Type 1 Diabetes MellitusNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Markers And Mechanisms Of Macrovascular Disease In IDDMNational Center For Research Resources2004–2005
- Markers And Mechanisms Of Vascular Disease In DiabetesNational Heart, Lung, And Blood Institute2002–2005
- Modified LDL, Autoimmunity And Vascular Disease In DiabetesNational Heart, Lung, And Blood Institute2001–2005
- Macrophage Activation And Lipoprotein MetabolismNational Heart, Lung, And Blood Institute1994–2001
- Modified LDL, Autoimmunity And Vascular Disease In IDDMNational Heart, Lung, And Blood Institute1996–2000
- Lipoprotein Metabolism And Cell Lipoprotein InteractionsNational Heart, Lung, And Blood Institute1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: